Across TCGA pan-cancer cohorts, RNU6-490P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNU6-490P’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RNU6-490P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-490P is over-expressed in tumor.
LUSC and STAD are the cancer types where RNU6-490P tumor–normal differential expression is most reproducible.